LB595 (Bcl-2 promoter CRE mut)
(Plasmid
#15243)
-
Depositing Lab
-
Publication
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 15243 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBSII KS+
- Backbone size w/o insert (bp) 2961
-
Vector typeBacterial Expression, Luciferase
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameB-cell lymphoma/leukemia-2
-
Alt nameBcl-2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)354
-
MutationMutated CRE site at -1537 changed from GTGACGTTA to GGGCCTTTA
-
Entrez GeneBCL2 (a.k.a. Bcl-2, PPP1R50)
-
Tag
/ Fusion Protein
- Luciferase (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SacII (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer T3 (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byMichael Cleary, Stanford University
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
LB595 (Bcl-2 promoter CRE mut) was a gift from Linda Boxer (Addgene plasmid # 15243 ; http://n2t.net/addgene:15243 ; RRID:Addgene_15243) -
For your References section:
NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Heckman CA, Mehew JW, Boxer LM. Oncogene. 2002 May 30. 21(24):3898-908. 10.1038/sj.onc.1205483 PubMed 12032828